- Home
- ALGS vs BCV Comparison
ALGS vs BCV Comparison
Compare ALGS & BCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- BCV
- Stock Information
- Founded
- ALGS 2018
- BCV 1971
- Country
- ALGS United States
- BCV United States
- Employees
- ALGS N/A
- BCV N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- BCV Finance/Investors Services
- Sector
- ALGS Health Care
- BCV Finance
- Exchange
- ALGS Nasdaq
- BCV Nasdaq
- Market Cap
- ALGS 118.8M
- BCV 107.4M
- IPO Year
- ALGS 2020
- BCV N/A
- Fundamental
- Price
- ALGS $18.63
- BCV $18.66
- Analyst Decision
- ALGS Strong Buy
- BCV
- Analyst Count
- ALGS 1
- BCV 0
- Target Price
- ALGS $75.00
- BCV N/A
- AVG Volume (30 Days)
- ALGS 268.0K
- BCV 26.3K
- Earning Date
- ALGS 03-11-2025
- BCV 01-01-0001
- Dividend Yield
- ALGS N/A
- BCV 8.13%
- EPS Growth
- ALGS N/A
- BCV N/A
- EPS
- ALGS N/A
- BCV N/A
- Revenue
- ALGS $5,997,000.00
- BCV N/A
- Revenue This Year
- ALGS N/A
- BCV N/A
- Revenue Next Year
- ALGS N/A
- BCV N/A
- P/E Ratio
- ALGS N/A
- BCV N/A
- Revenue Growth
- ALGS N/A
- BCV N/A
- 52 Week Low
- ALGS $6.76
- BCV $14.09
- 52 Week High
- ALGS $46.80
- BCV $18.11
- Technical
- Relative Strength Index (RSI)
- ALGS 33.33
- BCV 59.59
- Support Level
- ALGS $20.12
- BCV $18.25
- Resistance Level
- ALGS $24.33
- BCV $18.77
- Average True Range (ATR)
- ALGS 2.67
- BCV 0.18
- MACD
- ALGS -0.38
- BCV 0.03
- Stochastic Oscillator
- ALGS 4.38
- BCV 84.93
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.